GENERAL AMERICAN INVESTORS CO INC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 48 filers reported holding REPROS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
GENERAL AMERICAN INVESTORS CO INC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$76,000
-68.2%
237,504
-54.3%
0.01%
-70.8%
Q2 2017$239,000
-66.2%
519,829
-11.9%
0.02%
-65.2%
Q1 2017$708,000
-9.0%
589,7680.0%0.07%
-12.7%
Q4 2016$778,000
-47.6%
589,768
-17.1%
0.08%
-48.0%
Q3 2016$1,486,000
+132.9%
711,123
+79.5%
0.15%
+130.3%
Q2 2016$638,000
+66.1%
396,1230.0%0.07%
+65.0%
Q1 2016$384,000
-19.8%
396,1230.0%0.04%
-9.1%
Q4 2015$479,000
-87.3%
396,123
-22.2%
0.04%
-87.1%
Q3 2015$3,782,000
-12.1%
509,060
-15.4%
0.34%
-3.4%
Q2 2015$4,301,000
-1.5%
601,553
+18.3%
0.35%
-1.7%
Q1 2015$4,367,000
-13.8%
508,3750.0%0.36%
-11.4%
Q4 2014$5,068,000
+13.9%
508,375
+13.1%
0.40%
+14.1%
Q3 2014$4,450,000
+76.3%
449,475
+208.1%
0.36%
+73.2%
Q2 2014$2,524,000
+38.8%
145,891
+42.3%
0.20%
+34.9%
Q1 2014$1,818,000
-3.1%
102,5000.0%0.15%0.0%
Q4 2013$1,876,000
-31.7%
102,5000.0%0.15%
-36.4%
Q3 2013$2,747,000102,5000.24%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,001,000$970,0000.21%
Allegis Investment Advisors, LLC 341,669$331,0000.19%
GENERAL AMERICAN INVESTORS CO INC 396,123$384,0000.04%
Alambic Investment Management, L.P. 114,591$111,0000.04%
Gruss Capital Management LP 600,000$582,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 102,086$99,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 323,429$314,0000.01%
GSA CAPITAL PARTNERS LLP 27,931$27,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$3,0000.00%
Airain ltd 13,690$13,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders